Ashwa.30: A Bioactive-Optimized Ashwagandha Extract for Clinically Validated Low-Dose Efficacy.

Ashwa.30 is a clinically validated, dual-standardized extract of Withania somnifera developed using Bioactive Optimization Technology (B.O.T.). Unlike conventional high-dose ashwagandha products, Ashwa.30 achieves efficacy at a low 30 mg/day dosage through a synergistic combination of withanolides and a proprietary ATP-active fraction. Preclinical and clinical studies demonstrate significant improvements in endurance, stress resilience, and overall well-being. This manuscript summarizes the unique scientific rationale, development process, mechanisms of action, and formulation advantages of Ashwa.30, making it a next-generation solution for integrative and functional health applications.